'I'm Afraid I'll Fall': Smartphone AI Flags 86% of Older Adults at Risk for Locomotive Syndrome
Editor’s note: In Japan’s orthopedic community, specialists use the term "locomotive syndrome" to describe a decline in mobility caused by weakening...
Search results for "drugs"
Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million (approximately 521.
HK inno.N's K-CAB Secures Sixth Indication to Prevent Ulcers from Long-Term NSAID Use
HK inno.N’s gastroesophageal reflux disease drug K-CAB has expanded its approved uses to include the prevention of...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
Antihistamines Provide Minimal Relief for Atopic Dermatitis Itch, Study Finds
Antihistamines commonly used to ease itching from atopic dermatitis do not deliver a large enough benefit for patients...
Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors
Some immune cells surrounding a tumor actively attack it, while others create conditions that help it survive.
Sales Rise 11%, but Chong Kun Dang’s Q2 Operating Profit Slips 10%
Chong Kun Dang posted higher sales in the second quarter of this year, but its operating profit fell 10% from a year...
As the U.S. Reconsiders Direct-to-Consumer Drug Ads, What Lessons Should We Learn?
During a yearlong stay in the United States, one of the things that struck me most was how easy it is to come across...
South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway
"South Korea is among the top 10 markets in GSK’s global clinical research. More than 70 clinical programs are...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short
Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...